[Is the switch of fluoroquinolones from intravenous to oral administration useful in an intensive care unit? Economical approach].
Turc
J
J
Eve
O
O
Tran Van
D
D
Wey
P-F
PF
Martinez
J-Y
JY
D000284:Administration, Oral; D000890:Anti-Infective Agents / Q000008:administration & dosage* / Q000191:economics / Q000493:pharmacokinetics; D001682:Biological Availability; D002939:Ciprofloxacin / Q000008:administration & dosage* / Q000191:economics / Q000493:pharmacokinetics; D003363:Cost Control; D003422:Critical Care / Q000191:economics*; D016527:Drug Costs; D004750:Enteral Nutrition; D006801:Humans; D007275:Injections, Intravenous / Q000191:economics; D007362:Intensive Care Units / Q000191:economics; D015242:Ofloxacin / Q000008:administration & dosage* / Q000191:economics / Q000493:pharmacokinetics; D012189:Retrospective Studies
D000890:Anti-Infective Agents; D002939:Ciprofloxacin; D015242:Ofloxacin